186 related articles for article (PubMed ID: 30280772)
1. Down-regulation of miR-1236-3p is correlated with clinical progression and unfavorable prognosis in gastric cancer.
Zhu XP; Wang XL; Ma J; Fang YF; Zhang HJ; Zhang C; Feng MC
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5914-5919. PubMed ID: 30280772
[TBL] [Abstract][Full Text] [Related]
2. MiR-1236-3p serves as a new diagnostic and prognostic biomarker for gastric cancer.
An JX; Ma ZS; Ma MH; Shao S; Cao FL; Dai DQ
Cancer Biomark; 2019; 25(2):127-132. PubMed ID: 31045511
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and prognostic significance of miR-4317 expression in gastric cancer patients.
Zhang J; Tian ZL; Zhang WT; Cheng LM; Liu J; Cao YX; Zhang ZR
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2803-2808. PubMed ID: 31002131
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of tissue miR-338-3p predicts unfavorable prognosis of gastric cancer.
Liu S; Suo J; Wang C; Sun X; Wang D; He L; Zhang Y; Li W
Cancer Biomark; 2017 Dec; 21(1):117-122. PubMed ID: 29060930
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of miR-601 is associated with poor prognosis and tumor progression of gastric cancer.
Min C; Zhang A; Qin J
Diagn Pathol; 2019 Sep; 14(1):107. PubMed ID: 31547835
[TBL] [Abstract][Full Text] [Related]
6. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression.
Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
Clin Transl Oncol; 2017 Feb; 19(2):162-172. PubMed ID: 27173517
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance.
Hashiguchi Y; Nishida N; Mimori K; Sudo T; Tanaka F; Shibata K; Ishii H; Mochizuki H; Hase K; Doki Y; Mori M
Int J Oncol; 2012 May; 40(5):1477-82. PubMed ID: 22322911
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of miR-330-3p: a novel independent indicator of poor prognosis in human breast cancer.
Wang H; Chen SH; Kong P; Zhang LY; Zhang LL; Zhang NQ; Gu H
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1726-1730. PubMed ID: 29630118
[TBL] [Abstract][Full Text] [Related]
9. Reduced miR-490-3p expression is associated with poor prognosis of Helicobacter pylori induced gastric cancer.
Qu M; Li L; Zheng WC
Eur Rev Med Pharmacol Sci; 2017 Aug; 21(15):3384-3388. PubMed ID: 28829504
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of miR-145-5p correlates with poor prognosis in gastric cancer.
Zhang Y; Wen X; Hu XL; Cheng LZ; Yu JY; Wei ZB
Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3026-30. PubMed ID: 27460730
[TBL] [Abstract][Full Text] [Related]
11. Expression of miR-1294 is downregulated and predicts a poor prognosis in gastric cancer.
Shi YX; Ye BL; Hu BR; Ruan XJ
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5525-5530. PubMed ID: 30229824
[TBL] [Abstract][Full Text] [Related]
12. MiR-576-3p is a novel marker correlated with poor clinical outcome in bladder cancer.
Meng FM; Meng FM; Song XL
Eur Rev Med Pharmacol Sci; 2017 Mar; 21(5):973-977. PubMed ID: 28338199
[TBL] [Abstract][Full Text] [Related]
13. miR-148b-3p inhibits gastric cancer metastasis by inhibiting the Dock6/Rac1/Cdc42 axis.
Li X; Jiang M; Chen D; Xu B; Wang R; Chu Y; Wang W; Zhou L; Lei Z; Nie Y; Fan D; Shang Y; Wu K; Liang J
J Exp Clin Cancer Res; 2018 Mar; 37(1):71. PubMed ID: 29587866
[TBL] [Abstract][Full Text] [Related]
14. LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt/β-catenin pathway.
Yang XZ; Cheng TT; He QJ; Lei ZY; Chi J; Tang Z; Liao QX; Zhang H; Zeng LS; Cui SZ
Mol Cancer; 2018 Aug; 17(1):126. PubMed ID: 30134915
[TBL] [Abstract][Full Text] [Related]
15. Expression of microRNA-142-3p in cervical cancer and its correlation with prognosis.
Li M; Li BY; Xia H; Jiang LL
Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2346-2350. PubMed ID: 28617557
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of miR-141 downregulation in gastric cancer.
Lu YB; Hu JJ; Sun WJ; Duan XH; Chen X
Genet Mol Res; 2015 Dec; 14(4):17305-11. PubMed ID: 26681225
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of candidate microRNAs in gastric cancer: A validation study.
Zhang L; Huang Z; Zhang H; Zhu M; Zhu W; Zhou X; Liu P
Cancer Biomark; 2017; 18(3):221-230. PubMed ID: 27983528
[TBL] [Abstract][Full Text] [Related]
18. Prognostic potential of miR-21-3p in gastric cancer.
Sun X; Zhang K; Li D
J BUON; 2020; 25(6):2678-2682. PubMed ID: 33455113
[TBL] [Abstract][Full Text] [Related]
19. The microRNA-423-3p-Bim Axis Promotes Cancer Progression and Activates Oncogenic Autophagy in Gastric Cancer.
Kong P; Zhu X; Geng Q; Xia L; Sun X; Chen Y; Li W; Zhou Z; Zhan Y; Xu D
Mol Ther; 2017 Apr; 25(4):1027-1037. PubMed ID: 28254439
[TBL] [Abstract][Full Text] [Related]
20. Downregulated PITX1 Modulated by MiR-19a-3p Promotes Cell Malignancy and Predicts a Poor Prognosis of Gastric Cancer by Affecting Transcriptionally Activated PDCD5.
Qiao F; Gong P; Song Y; Shen X; Su X; Li Y; Wu H; Zhao Z; Fan H
Cell Physiol Biochem; 2018; 46(6):2215-2231. PubMed ID: 29734189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
